Past Symposia

35. Trento, 24-25 June 2024
CANCER AS A SYSTEMIC DISEASE: INTERACTIONS BETWEEN TUMOR AND HOST

34. Trento, 19 – 20 June 2023
NEW TECHNOLOGIES FOR STUDYING AND TREATING CANCER

33. Trento, 13 – 14 June 2022
WHAT ARE THE OBSTACLES TO CANCER IMMUNOTHERAPY SUCCESS?

32. Virtual, 21 – 22 June 2021
AGING AND CANCER

31. Trento, 17 – 18 June 2019
CANCER AS CORRUPTED TISSUE

30. Trento, 25 – 26 June 2018
OVERCOMING THE INNATE RESISTANCE OF CANCER TO THERAPY

29. Trento, 22 – 23 June 2017
BUILDING NEW BRIDGES BETWEEN BASIC AND CANCER SCIENCE

28. Trento, 20 – 21 June 2016
INITIAL STEPS ON THE ROUTE TO TUMORIGENESIS

27. Trento, 18 – 20 June 2015
CHALLENGING ROADBLOCKS TO CANCER CURES

25. Trento, 20 – 22 June 2013
METABOLISM AND TUMORIGENESIS

24. Trento, 14 – 16 June 2012
MOLECULAR BASIS FOR RESISTANCE TO TARGETED AGENTS

23. Trento, 16 – 18 June 2011
ENGINEERING AND NANOTECHNOLOGY IN CANCER

21. Trento 11 – 13 June 2009
UNCONVENTIONAL THERAPEUTIC TARGETS IN CANCER

20. Trento 11 – 13 June 2008
MOLECULAR BIOLOGY OF CANCER: 20 YEARS OF PROGRESS PUNCTUATED BY THE PEZCOLLER SYMPOSIA

19. Trento 14 – 16 June 2007
HYPOTHESIS DRIVEN CLINICAL INVESTIGATION IN CANCER

18. Trento: 27 – 29 June 2006
TUMOR MICROENVIRONMENT: HETEROTYPIC INTERACTIONS

17. Trento: 16 – 18 June 2005
MOLECULAR UNDERSTANDING OF SOLID TUMORS

16. Trento, 10 – 12 June 2004
STEM CELLS AND EPIGENESIS IN CANCER

15. Rovereto, 12 – 14 June 2003
MOLECULAR IN VIVO VISUALISATION OF CANCER CELLS

14. Trento, 30 May – 1 June 2002
THE NOVEL DICHOTOMY OF IMMUNE INTERACTIONS WITH TUMORS

13. Rovereto, 31 May – 2 June 2001
FOCUSING ANALYTICAL TOOLS ON COMPLEXITY IN CANCER

12. Trento, 1 -3 June 2000
SIGNALING CROSS-TALKS IN CANCER CELLS

11. Rovereto, 5- 7 June 1999
MOLECULAR HORIZONS IN CANCER THERAPEUTICS

10. Trento, 29 June – 1 July 1998
THE GENETICS OF CANCER SUSCEPTIBILITY

8. Trento, 17 – 19 June 1996
GENOMIC INSTABILITY AND IMMORTALITY IN CANCER

7. Trento, 14 – 16 giugno 1995
CANCER GENES. FUNCTIONAL ASPECTS

6. Rovereto, 29 giugno – 1 luglio 1994
NORMAL AND MALIGNANT HEMATOPOIESIS: NEW ADVANCES

5. Trento, 9 – 11 giugno 1993
APOPTOSIS

4. Rovereto, 24 – 26 giugno 1992
ADHESION MOLECULES: CELLULAR RECOGNITION MECHANISMS

3. Trento, 5 – 7 giugno 1991
TUMOR SUPPRESSOR GENES

2. Rovereto, 11 – 13 giugno 1990
THE THERAPEUTIC IMPLICATIONS OF THE MOLECULAR BIOLOGY OF BREAST CANCER

1. Trento, 19 – 21 giugno 1989
DRUG RESISTANCE: MECHANISMS AND REVERSAL